Go Pro

XOS (XOS) Financials

XOS logo
$2.14 -0.07 (-3.17%)
Closing price 04:00 PM Eastern
Extended Trading
$2.21 +0.07 (+3.08%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for XOS

Annual Income Statements for XOS

This table shows XOS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-17 23 -74 -75 -50 -25
Consolidated Net Income / (Loss)
-17 23 -73 -76 -50 -25
Net Income / (Loss) Continuing Operations
-17 23 -73 -76 -50 -25
Total Pre-Tax Income
-17 23 -73 -76 -50 -25
Total Operating Income
-12 -53 -111 -65 -46 -33
Total Gross Profit
0.30 -2.36 -30 -1.29 3.97 2.72
Total Revenue
2.64 5.05 36 45 56 46
Operating Revenue
2.64 5.05 36 45 56 46
Total Cost of Revenue
2.34 7.41 66 46 52 43
Operating Cost of Revenue
2.34 7.41 66 46 52 43
Total Operating Expenses
12 51 81 64 50 36
Selling, General & Admin Expense
3.61 27 41 38 35 25
Marketing Expense
1.55 3.52 9.55 6.39 4.13 3.01
Research & Development Expense
7.02 20 31 20 11 8.00
Total Other Income / (Expense), net
-4.80 77 38 -11 -4.56 7.74
Other Income / (Expense), net
-4.80 91 38 -11 -4.56 7.74
Income Tax Expense
0.00 0.00 0.01 0.02 0.04 0.02
Basic Earnings per Share
($0.23) $0.22 ($13.31) ($13.11) ($6.69) ($2.71)
Weighted Average Basic Shares Outstanding
72.03M 105.57M 5.51M 5.79M 7.50M 9.36M
Diluted Earnings per Share
($0.23) $0.22 ($13.32) ($13.11) ($6.69) ($2.71)
Weighted Average Diluted Shares Outstanding
72.03M 107.79M 5.81M 5.79M 7.50M 9.36M
Weighted Average Basic & Diluted Shares Outstanding
- 163.23M 169.01M 7.75M 8.10M 11.98M

Quarterly Income Statements for XOS

This table shows XOS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-14 -13 -11 -9.66 -11 -19 -10 -7.51 2.12 -9.75 -4.95
Consolidated Net Income / (Loss)
-14 -14 -11 -9.66 -11 -19 -10 -7.51 2.12 -9.75 -4.95
Net Income / (Loss) Continuing Operations
-14 -14 -11 -9.66 -11 -19 -10 -7.51 2.12 -9.75 -4.95
Total Pre-Tax Income
-14 -14 -11 -9.66 -11 -19 -10 -7.49 2.12 -9.75 -4.95
Total Operating Income
-13 -12 -10 -11 -9.69 -15 -9.27 -7.08 -6.99 -9.74 -4.68
Total Gross Profit
1.99 1.33 2.79 2.03 2.86 -3.72 1.21 1.62 2.53 -2.64 4.33
Total Revenue
17 18 13 16 16 11 5.88 18 17 5.22 11
Operating Revenue
17 18 13 16 16 11 5.88 18 17 5.22 11
Total Cost of Revenue
15 17 10 14 13 15 4.67 17 14 7.86 6.89
Operating Cost of Revenue
15 17 10 14 13 15 4.67 17 14 7.86 6.89
Total Operating Expenses
15 13 13 13 13 11 10 8.70 9.53 7.10 9.01
Selling, General & Admin Expense
8.55 7.74 8.96 9.18 8.90 8.05 7.90 5.91 6.46 4.54 6.07
Marketing Expense
1.55 1.28 1.00 1.22 1.04 0.87 0.65 0.71 0.97 0.68 0.92
Research & Development Expense
4.52 4.14 3.07 3.00 2.62 1.94 1.93 2.09 2.10 1.88 2.03
Total Other Income / (Expense), net
-1.48 -2.13 -0.76 1.71 -0.82 -4.70 -0.85 -0.41 9.12 -0.06 -0.28
Other Income / (Expense), net
-1.48 -2.13 -0.76 1.71 -0.82 -4.70 -0.85 -0.41 9.12 -0.06 -0.28
Income Tax Expense
0.00 0.01 0.01 0.00 0.00 0.02 0.01 0.01 -0.00 - 0.01
Basic Earnings per Share
($2.40) ($2.32) ($1.80) ($1.23) ($1.32) ($2.53) ($1.26) ($0.91) $0.22 ($1.04) ($0.43)
Weighted Average Basic Shares Outstanding
5.88M 5.79M 6.11M 7.86M 7.98M 7.50M 8.08M 8.29M 9.69M 9.36M 11.57M
Diluted Earnings per Share
($2.40) ($2.32) ($1.80) ($1.23) ($1.32) ($2.53) ($1.26) ($0.91) $0.22 ($1.04) ($0.43)
Weighted Average Diluted Shares Outstanding
5.88M 5.79M 6.11M 7.86M 7.98M 7.50M 8.08M 8.29M 9.75M 9.36M 11.57M
Weighted Average Basic & Diluted Shares Outstanding
177.88M 7.75M 7.87M 8.00M 8.03M 8.10M 8.31M 8.69M 11.33M 11.98M 12.12M

Annual Cash Flow Statements for XOS

This table details how cash moves in and out of XOS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
10 8.82 19 -27 -0.64 3.04
Net Cash From Operating Activities
-12 -89 -128 -39 -49 5.37
Net Cash From Continuing Operating Activities
-12 -89 -128 -39 -49 5.37
Net Income / (Loss) Continuing Operations
-17 23 -73 -76 -50 -25
Consolidated Net Income / (Loss)
-17 23 -73 -76 -50 -25
Depreciation Expense
0.30 0.74 2.07 3.31 3.34 2.18
Amortization Expense
- 0.00 5.48 12 4.68 4.12
Non-Cash Adjustments To Reconcile Net Income
3.22 -73 -30 6.66 16 -1.15
Changes in Operating Assets and Liabilities, net
0.82 -40 -32 14 -23 26
Net Cash From Investing Activities
-0.41 -155 83 51 51 0.06
Net Cash From Continuing Investing Activities
-0.41 -155 83 51 51 0.06
Purchase of Property, Plant & Equipment
-0.41 -4.92 -14 -1.39 -0.30 0.00
Acquisitions
- - - 0.00 51 0.00
Sale of Property, Plant & Equipment
- - 0.00 1.30 0.13 0.06
Net Cash From Financing Activities
23 253 65 -38 -3.03 -2.38
Net Cash From Continuing Financing Activities
23 253 65 -38 -3.03 -2.38
Repayment of Debt
0.07 -0.44 -3.36 -42 -5.18 -6.37
Issuance of Debt
13 0.00 58 3.77 3.11 2.61
Issuance of Common Equity
0.00 196 4.31 1.20 0.05 2.40
Other Financing Activities, net
0.01 26 5.87 -1.05 -1.00 -1.02
Cash Income Taxes Paid
- - - 0.00 0.02 0.05

Quarterly Cash Flow Statements for XOS

This table details how cash moves in and out of XOS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-4.44 -12 36 -27 -12 1.81 -6.24 4.03 5.28 -0.03 -4.19
Net Cash From Operating Activities
-8.61 -0.63 -15 -26 -12 3.30 -4.76 4.65 3.08 2.40 -1.59
Net Cash From Continuing Operating Activities
-8.61 -0.63 -15 -26 -12 3.30 -4.76 4.65 3.08 2.40 -1.59
Net Income / (Loss) Continuing Operations
-14 -14 -11 -9.66 -11 -19 -10 -7.51 2.12 -9.75 -4.95
Consolidated Net Income / (Loss)
-14 -14 -11 -9.66 -11 -19 -10 -7.51 2.12 -9.75 -4.95
Depreciation Expense
1.71 0.22 0.91 0.87 0.77 0.79 0.51 0.56 0.53 0.58 0.56
Amortization Expense
2.22 2.41 1.14 1.13 1.12 1.29 1.09 1.08 1.00 0.95 0.96
Non-Cash Adjustments To Reconcile Net Income
1.05 1.06 1.80 1.18 2.69 10 1.52 -0.13 -5.95 3.42 1.80
Changes in Operating Assets and Liabilities, net
0.53 9.51 -7.44 -20 -5.59 9.90 2.32 11 5.37 7.21 0.05
Net Cash From Investing Activities
14 -0.22 51 -0.13 -0.02 - 0.00 - 0.04 0.02 0.31
Net Cash From Continuing Investing Activities
14 -0.22 51 -0.13 -0.02 - 0.00 - 0.04 0.02 0.31
Purchase of Property, Plant & Equipment
0.19 -0.22 -0.03 -0.13 -0.15 - 0.00 - - - -0.02
Sale of Property, Plant & Equipment
0.80 - - - - - 0.00 - - 0.02 0.33
Net Cash From Financing Activities
-10 -11 -1.09 -0.48 0.04 -1.49 -1.48 -0.62 2.16 -2.44 -2.92
Net Cash From Continuing Financing Activities
-10 -11 -1.09 -0.48 0.04 -1.49 -1.48 -0.62 2.16 -2.44 -2.92
Repayment of Debt
-12 -11 -1.33 -1.27 -1.16 -1.42 -1.43 -1.65 -1.05 -2.24 -2.25
Issuance of Debt
1.58 - 0.45 1.33 1.32 - 0.09 1.58 0.93 - 0.00
Other Financing Activities, net
-0.17 -0.13 -0.26 -0.55 -0.12 -0.07 -0.14 -0.55 -0.16 -0.17 -0.66

Annual Balance Sheets for XOS

This table presents XOS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14 229 190 94 98 60
Total Current Assets
13 166 163 72 82 50
Cash & Equivalents
10 16 36 12 11 14
Accounts Receivable
0.41 3.35 8.24 15 27 6.04
Inventories, net
1.87 31 58 38 37 25
Prepaid Expenses
0.06 18 8.10 7.07 7.87 4.84
Plant, Property, & Equipment, net
1.08 7.43 19 15 6.11 4.32
Total Noncurrent Assets
0.00 55 8.15 7.33 9.92 6.17
Other Noncurrent Operating Assets
0.00 0.51 8.15 7.33 9.92 6.17
Total Liabilities & Shareholders' Equity
14 229 190 94 98 60
Total Liabilities
33 54 78 48 65 37
Total Current Liabilities
33 16 46 20 47 24
Short-Term Debt
19 0.00 27 0.00 20 6.50
Accounts Payable
1.17 10 2.90 2.76 8.93 2.47
Other Current Liabilities
13 5.86 16 17 18 15
Total Noncurrent Liabilities
0.17 38 32 29 18 13
Long-Term Debt
0.17 0.00 20 20 0.00 12
Other Noncurrent Operating Liabilities
0.00 38 12 9.00 18 1.42
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-27 174 112 45 34 23
Total Preferred & Common Equity
-27 174 112 45 34 23
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-27 174 112 45 34 23
Common Stock
0.30 179 190 198 237 252
Retained Earnings
-27 -4.09 -77 -153 -203 -229

Quarterly Balance Sheets for XOS

This table presents XOS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
114 135 123 121 88 80 74 54
Total Current Assets
91 113 100 98 73 67 63 45
Cash & Equivalents
23 46 20 8.43 4.76 8.79 14 9.85
Accounts Receivable
11 20 30 36 22 18 15 7.40
Inventories, net
49 37 41 42 38 31 25 24
Prepaid Expenses
7.83 8.58 8.34 9.55 8.12 8.75 7.86 4.35
Plant, Property, & Equipment, net
16 14 13 12 5.21 4.91 4.37 3.81
Total Noncurrent Assets
7.17 8.54 10 10 9.38 8.80 6.91 5.34
Other Noncurrent Operating Assets
7.17 8.54 10 10 9.38 8.80 6.91 5.34
Total Liabilities & Shareholders' Equity
114 135 123 121 88 80 74 54
Total Liabilities
57 67 64 70 63 62 43 35
Total Current Liabilities
27 22 20 50 45 30 26 24
Short-Term Debt
7.94 - - 20 20 4.49 6.00 7.00
Accounts Payable
2.43 2.27 3.10 8.92 6.51 4.93 4.86 1.94
Other Current Liabilities
17 20 17 21 19 21 15 15
Total Noncurrent Liabilities
29 45 44 19 18 32 17 11
Long-Term Debt
20 20 20 0.00 - 16 14 10
Other Noncurrent Operating Liabilities
9.55 25 24 19 18 16 2.79 0.69
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
58 68 59 51 25 18 31 20
Total Preferred & Common Equity
58 68 59 51 25 18 31 20
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
58 68 59 51 25 18 31 20
Common Stock
197 232 233 235 238 239 250 253
Retained Earnings
-139 -164 -174 -184 -214 -221 -219 -234

Annual Metrics And Ratios for XOS

This table displays calculated financial ratios and metrics derived from XOS's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
46,875,000.00 162,904,938.00 336,068,436.00 177,882,898.00 8,029,344.00 11,334,192.00
DEI Adjusted Shares Outstanding
1,562,500.00 5,430,165.00 11,202,281.00 5,929,430.00 8,029,344.00 11,334,192.00
DEI Earnings Per Adjusted Shares Outstanding
-10.67 4.31 -6.58 -12.67 -6.25 -2.23
Growth Metrics
- - - - - -
Revenue Growth
0.00% 91.14% 620.60% 22.40% 25.69% -17.81%
EBITDA Growth
0.00% 333.60% -271.98% 8.18% 29.77% 55.10%
EBIT Growth
0.00% 325.04% -295.48% -3.42% 33.48% 49.75%
NOPAT Growth
0.00% -539.57% -46.65% 41.66% 29.39% 27.88%
Net Income Growth
0.00% 240.40% -413.34% -3.43% 33.86% 49.52%
EPS Growth
0.00% 195.65% -413.34% 1.58% 48.97% 59.49%
Operating Cash Flow Growth
0.00% -620.50% -43.95% 69.30% -24.20% 111.00%
Free Cash Flow Firm Growth
0.00% 0.00% -102.79% 79.20% 28.02% 60.79%
Invested Capital Growth
0.00% 151.74% 1,117.72% -23.02% -20.37% -34.84%
Revenue Q/Q Growth
0.00% 0.00% 16.94% 28.24% -10.98% -11.97%
EBITDA Q/Q Growth
0.00% 0.00% -70.83% 6.67% -16.01% 31.12%
EBIT Q/Q Growth
0.00% 0.00% -74.07% 7.01% -11.76% 26.54%
NOPAT Q/Q Growth
0.00% 0.00% -0.42% 17.82% -6.36% 12.75%
Net Income Q/Q Growth
0.00% 0.00% -74.07% 7.17% -11.45% 26.71%
EPS Q/Q Growth
0.00% 0.00% -74.07% 4.79% -19.68% 24.09%
Operating Cash Flow Q/Q Growth
0.00% -59.81% 9.48% 35.62% 7.45% -14.35%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 27.38% 28.69% -332.67%
Invested Capital Q/Q Growth
0.00% 0.00% -9.53% -13.81% -30.88% -25.00%
Profitability Metrics
- - - - - -
Gross Margin
11.36% -46.79% -82.55% -2.90% 7.09% 5.92%
EBITDA Margin
-619.88% 757.59% -180.81% -135.64% -75.78% -41.41%
Operating Margin
-449.53% -1,052.99% -306.10% -145.91% -81.97% -71.93%
EBIT Margin
-631.09% 743.01% -201.55% -170.30% -90.13% -55.11%
Profit (Net Income) Margin
-631.09% 463.57% -201.58% -170.35% -89.63% -55.05%
Tax Burden Percent
100.00% 99.99% 100.01% 100.03% 100.07% 100.09%
Interest Burden Percent
100.00% 62.40% 100.00% 100.00% 99.38% 99.81%
Effective Tax Rate
0.00% 0.01% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -207.36% -73.98% -66.86% -65.85%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -211.73% 102.97% -276.05% -98.04%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 156.17% -22.47% -60.44% -23.15%
Return on Equity (ROE)
86.20% 30.18% -51.19% -96.45% -127.30% -89.00%
Cash Return on Invested Capital (CROIC)
0.00% -1,224.92% -377.01% -47.96% -44.18% -23.66%
Operating Return on Assets (OROA)
-121.00% 30.94% -35.03% -53.47% -52.53% -31.94%
Return on Assets (ROA)
-121.00% 19.30% -35.03% -53.48% -52.24% -31.91%
Return on Common Equity (ROCE)
121.25% 28.65% -51.19% -96.45% -127.30% -89.00%
Return on Equity Simple (ROE_SIMPLE)
61.28% 13.42% -65.42% -167.81% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.31 -53 -78 -45 -32 -23
NOPAT Margin
-314.67% -1,052.90% -214.27% -102.14% -57.38% -50.35%
Net Nonoperating Expense Percent (NNEP)
100.57% 95.46% 4.37% -176.95% 209.19% 32.19%
Return On Investment Capital (ROIC_SIMPLE)
- - - -69.84% -59.93% -55.42%
Cost of Revenue to Revenue
88.64% 146.79% 182.55% 102.90% 92.91% 94.08%
SG&A Expenses to Revenue
136.65% 538.77% 112.97% 84.67% 62.69% 53.92%
R&D to Revenue
265.62% 397.72% 84.34% 44.00% 18.99% 17.39%
Operating Expenses to Revenue
460.89% 1,006.20% 223.55% 143.02% 89.06% 77.85%
Earnings before Interest and Taxes (EBIT)
-17 38 -73 -76 -50 -25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-16 38 -66 -60 -42 -19
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 2.94 0.66 1.05 0.77 0.88
Price to Tangible Book Value (P/TBV)
0.00 2.94 0.66 1.05 0.77 0.88
Price to Revenue (P/Rev)
178.73 101.65 2.05 1.06 0.46 0.45
Price to Earnings (P/E)
0.00 21.93 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 4.56% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 60.38 0.46 1.04 0.82 0.90
Enterprise Value to Revenue (EV/Rev)
184.86 68.24 0.87 1.25 0.63 0.54
Enterprise Value to EBITDA (EV/EBITDA)
0.00 9.01 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 9.18 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 4.66
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
-0.97 0.00 0.42 0.44 0.59 0.79
Long-Term Debt to Equity
-0.01 0.00 0.18 0.44 0.00 0.52
Financial Leverage
-0.43 -1.03 -0.74 -0.22 0.22 0.24
Leverage Ratio
-0.71 1.56 1.46 1.80 2.44 2.79
Compound Leverage Factor
-0.71 0.98 1.46 1.80 2.42 2.78
Debt to Total Capital
-2,798.80% 0.00% 29.42% 30.59% 37.27% 44.27%
Short-Term Debt to Total Capital
-2,773.91% 0.00% 16.91% 0.00% 37.27% 15.56%
Long-Term Debt to Total Capital
-24.89% 0.00% 12.51% 30.59% 0.00% 28.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-1,178.71% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
4,077.51% 100.00% 70.58% 69.41% 62.73% 55.73%
Debt to EBITDA
-1.14 0.00 -0.71 -0.33 -0.47 -0.97
Net Debt to EBITDA
-0.51 0.00 0.65 -0.14 -0.21 -0.23
Long-Term Debt to EBITDA
-0.01 0.00 -0.30 -0.33 0.00 -0.63
Debt to NOPAT
-2.25 0.00 -0.60 -0.44 -0.62 -0.80
Net Debt to NOPAT
-1.00 0.00 0.55 -0.18 -0.28 -0.19
Long-Term Debt to NOPAT
-0.02 0.00 -0.25 -0.44 0.00 -0.52
Altman Z-Score
0.19 6.99 -0.34 -3.23 -3.34 -5.08
Noncontrolling Interest Sharing Ratio
-40.66% 5.07% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.39 10.38 3.57 3.66 1.76 2.11
Quick Ratio
0.33 7.14 2.07 1.37 0.81 0.85
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -70 -142 -29 -21 -8.32
Operating Cash Flow to CapEx
-3,031.45% -1,808.65% -906.68% -43,651.11% -27,259.78% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -4.95 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 -6.30 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 -6.65 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.19 0.04 0.17 0.31 0.58 0.58
Accounts Receivable Turnover
6.47 2.68 6.28 3.81 2.66 2.80
Inventory Turnover
1.25 0.45 1.50 0.96 1.40 1.41
Fixed Asset Turnover
2.44 1.19 2.80 2.68 5.39 8.82
Accounts Payable Turnover
2.00 1.31 10.20 16.21 8.90 7.59
Days Sales Outstanding (DSO)
56.39 135.97 58.15 95.83 137.01 130.57
Days Inventory Outstanding (DIO)
291.10 806.60 243.01 379.97 261.17 259.52
Days Payable Outstanding (DPO)
182.11 278.06 35.78 22.52 41.02 48.10
Cash Conversion Cycle (CCC)
165.37 664.51 265.39 453.29 357.16 341.99
Capital & Investment Metrics
- - - - - -
Invested Capital
-11 5.71 69 53 43 28
Invested Capital Turnover
-0.24 -1.90 0.97 0.72 1.17 1.31
Increase / (Decrease) in Invested Capital
0.00 17 64 -16 -11 -15
Enterprise Value (EV)
488 344 32 56 35 25
Market Capitalization
472 513 74 47 26 21
Book Value per Share
($0.58) $1.07 $0.67 $0.25 $4.19 $2.05
Tangible Book Value per Share
($0.58) $1.07 $0.67 $0.25 $4.19 $2.05
Total Capital
-0.67 174 159 65 54 42
Total Debt
19 0.00 47 20 20 19
Total Long-Term Debt
0.17 0.00 20 20 0.00 12
Net Debt
8.31 -169 -43 8.28 8.97 4.46
Capital Expenditures (CapEx)
0.41 4.92 14 0.09 0.18 -0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-12 36 55 40 45 19
Debt-free Net Working Capital (DFNWC)
-1.75 150 144 52 56 33
Net Working Capital (NWC)
-20 150 117 52 36 26
Net Nonoperating Expense (NNE)
8.36 -77 -4.62 30 18 2.16
Net Nonoperating Obligations (NNO)
8.31 -169 -43 8.28 8.97 4.46
Total Depreciation and Amortization (D&A)
0.30 0.74 7.55 15 8.03 6.30
Debt-free, Cash-free Net Working Capital to Revenue
-458.54% 715.19% 151.09% 90.92% 79.71% 40.61%
Debt-free Net Working Capital to Revenue
-66.30% 2,970.98% 396.65% 117.07% 99.36% 71.14%
Net Working Capital to Revenue
-766.87% 2,970.98% 322.84% 117.07% 63.67% 57.01%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $6.60 ($13.20) ($13.11) ($6.69) ($2.71)
Adjusted Weighted Average Basic Shares Outstanding
0.00 3.52M 5.51M 5.79M 7.50M 9.36M
Adjusted Diluted Earnings per Share
$0.00 $6.60 ($13.20) ($13.11) ($6.69) ($2.71)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 3.59M 5.81M 5.79M 7.50M 9.36M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 5.44M 5.63M 7.75M 8.10M 11.98M
Normalized Net Operating Profit after Tax (NOPAT)
-8.31 -53 -78 -45 -32 -23
Normalized NOPAT Margin
-314.67% -1,052.90% -214.27% -102.14% -57.38% -50.35%
Pre Tax Income Margin
-631.09% 463.61% -201.55% -170.30% -89.57% -55.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 2.66 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 -3.77 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 2.31 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 -4.12 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.02% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for XOS

This table displays calculated financial ratios and metrics derived from XOS's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
176,018,770.00 177,882,898.00 7,750,258.00 7,873,364.00 8,003,858.00 8,029,344.00 8,102,993.00 8,311,692.00 8,690,583.00 11,334,192.00 23,965,254.00
DEI Adjusted Shares Outstanding
5,867,292.00 5,929,430.00 7,750,258.00 7,873,364.00 8,003,858.00 8,029,344.00 8,102,993.00 8,311,692.00 8,690,583.00 11,334,192.00 23,965,254.00
DEI Earnings Per Adjusted Shares Outstanding
-2.39 -2.26 -1.42 -1.23 -1.31 -2.36 -1.26 -0.90 0.24 -0.86 -0.21
Growth Metrics
- - - - - - - - - - -
Revenue Growth
51.67% 114.40% 180.22% 226.78% -5.43% -37.56% -55.33% 18.40% 4.50% -54.51% 90.93%
EBITDA Growth
42.89% 27.57% 54.78% 59.87% 15.36% -51.65% 4.67% 23.66% 142.43% 51.88% 59.62%
EBIT Growth
29.35% 29.06% 54.52% 59.03% 25.50% -38.02% 7.98% 22.44% 120.18% 49.14% 51.02%
NOPAT Growth
59.46% 54.37% 48.86% 44.50% 23.24% -23.20% 9.51% 37.71% -3.20% 33.17% 49.54%
Net Income Growth
29.33% 29.77% 54.78% 59.02% 25.48% -37.27% 7.43% 22.33% 120.20% 48.62% 51.37%
EPS Growth
29.33% 33.52% 58.33% 70.29% 45.00% -9.05% 30.00% 26.02% 116.67% 58.89% 65.87%
Operating Cash Flow Growth
71.07% 97.18% 4.81% -76.59% -33.72% 622.66% 67.40% 117.87% 126.72% -27.26% 66.61%
Free Cash Flow Firm Growth
104.13% 109.42% 132.92% 61.43% -207.56% -91.04% -134.41% 1,080.88% 377.37% 1,059.59% 261.87%
Invested Capital Growth
-19.20% -23.02% -38.00% -8.61% -0.70% -20.37% -1.05% -49.49% -39.96% -34.84% -32.70%
Revenue Q/Q Growth
251.20% 10.06% -28.37% 18.03% 1.64% -27.33% -48.76% 212.86% -10.29% -68.36% 115.04%
EBITDA Q/Q Growth
46.68% -11.32% 21.08% 14.33% -12.46% -99.45% 50.39% 31.83% 162.51% -326.20% 58.37%
EBIT Q/Q Growth
40.18% 1.01% 21.23% 12.17% -8.79% -83.38% 47.48% 26.36% 128.31% -562.05% 49.42%
NOPAT Q/Q Growth
38.36% 6.31% 13.40% -10.98% 14.75% -50.37% 36.39% 23.61% -41.24% 2.62% 51.98%
Net Income Q/Q Growth
40.17% 1.98% 20.42% 12.18% -8.79% -80.57% 46.34% 26.32% 128.29% -559.35% 49.21%
EPS Q/Q Growth
40.17% 3.33% 22.41% 31.67% -7.32% -91.67% 50.20% 27.78% 124.18% -572.73% 58.65%
Operating Cash Flow Q/Q Growth
41.47% 92.67% -2,212.04% -78.13% 55.68% 128.64% -244.21% 197.67% -33.76% -22.03% -166.19%
Free Cash Flow Firm Q/Q Growth
193.13% 30.65% 128.45% -113.88% -159.72% 110.89% -976.85% 495.57% -26.56% -54.48% 22.40%
Invested Capital Q/Q Growth
-3.05% -13.81% -24.35% 44.56% 5.35% -30.88% -6.00% -26.21% 25.25% -25.00% -2.90%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
11.89% 7.22% 21.18% 13.07% 18.14% -32.40% 20.60% 8.80% 15.34% -50.52% 38.61%
EBITDA Margin
-60.98% -61.67% -67.95% -49.32% -54.57% -149.79% -145.02% -31.80% 22.16% -158.43% -30.67%
Operating Margin
-75.62% -64.37% -77.82% -73.18% -61.37% -127.00% -157.66% -38.50% -42.39% -186.57% -41.67%
EBIT Margin
-84.48% -75.98% -83.56% -62.18% -66.55% -167.94% -172.14% -40.73% 12.85% -187.74% -44.16%
Profit (Net Income) Margin
-84.49% -75.24% -83.60% -62.20% -66.57% -165.43% -173.26% -40.80% 12.87% -186.82% -44.12%
Tax Burden Percent
100.02% 100.10% 100.05% 100.04% 100.04% 100.13% 100.12% 100.17% 100.09% 100.00% 100.10%
Interest Burden Percent
100.00% 98.93% 100.00% 100.00% 100.00% 98.38% 100.53% 100.00% 100.00% 99.51% 99.82%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.09% 0.00% 0.00%
Return on Invested Capital (ROIC)
-26.47% -32.63% -54.61% -53.34% -43.68% -103.58% -133.50% -31.56% -44.96% -170.81% -44.72%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.96% -0.31% -39.83% 3.43% -92.56% -205.36% -72.51% -80.25% 64.27% -214.50% -59.72%
Return on Net Nonoperating Assets (RNNOA)
1.00% 0.07% 13.11% -0.16% -13.03% -44.96% 9.50% -10.83% 13.11% -50.65% -29.96%
Return on Equity (ROE)
-25.48% -32.57% -41.51% -53.50% -56.71% -148.54% -124.00% -42.39% -31.85% -221.45% -74.68%
Cash Return on Invested Capital (CROIC)
-58.48% -47.96% -26.17% -43.65% -48.13% -44.18% -77.05% 1.17% -3.90% -23.66% -20.47%
Operating Return on Assets (OROA)
-17.68% -23.85% -29.80% -30.74% -35.65% -97.89% -75.27% -20.60% 6.91% -108.82% -31.91%
Return on Assets (ROA)
-17.69% -23.62% -29.81% -30.76% -35.66% -96.42% -75.76% -20.64% 6.92% -108.29% -31.88%
Return on Common Equity (ROCE)
-25.48% -32.57% -41.51% -53.50% -56.71% -148.54% -124.00% -42.39% -31.85% -221.45% -74.68%
Return on Equity Simple (ROE_SIMPLE)
-141.94% 0.00% -92.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.84 -8.28 -7.17 -7.96 -6.78 -10 -6.49 -4.96 -7.00 -6.82 -3.27
NOPAT Margin
-52.93% -45.06% -54.48% -51.22% -42.96% -88.90% -110.36% -26.95% -42.43% -130.60% -29.17%
Net Nonoperating Expense Percent (NNEP)
-22.51% -32.32% -14.78% -56.77% 48.88% 101.78% -60.98% 48.69% -109.23% 43.69% 15.01%
Return On Investment Capital (ROIC_SIMPLE)
- -12.72% -8.17% -10.05% -9.58% -19.04% -14.49% -12.93% -13.71% -16.31% -8.90%
Cost of Revenue to Revenue
88.11% 92.78% 78.82% 86.93% 81.86% 132.40% 79.40% 91.20% 84.66% 150.52% 61.39%
SG&A Expenses to Revenue
51.19% 42.10% 68.07% 59.07% 56.35% 70.17% 134.31% 32.11% 39.13% 86.95% 54.03%
R&D to Revenue
27.05% 22.55% 23.36% 19.30% 16.59% 16.87% 32.83% 11.35% 12.73% 36.05% 18.08%
Operating Expenses to Revenue
87.51% 71.59% 99.00% 86.24% 79.51% 94.61% 178.26% 47.30% 57.73% 136.05% 80.28%
Earnings before Interest and Taxes (EBIT)
-14 -14 -11 -9.66 -11 -19 -10 -7.49 2.12 -9.80 -4.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-10 -11 -8.94 -7.66 -8.62 -17 -8.53 -5.85 3.66 -8.27 -3.44
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.05 1.05 1.17 0.92 0.72 0.77 0.98 1.37 0.76 0.88 0.99
Price to Tangible Book Value (P/TBV)
1.05 1.05 1.17 0.92 0.72 0.77 0.98 1.37 0.76 0.88 0.99
Price to Revenue (P/Rev)
1.74 1.06 1.50 0.85 0.58 0.46 0.50 0.49 0.45 0.45 0.38
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.05 1.04 1.29 0.92 0.77 0.82 0.99 1.23 0.79 0.90 0.99
Enterprise Value to Revenue (EV/Rev)
1.87 1.25 0.98 0.84 0.75 0.63 0.81 0.70 0.56 0.54 0.52
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.69 4.66 3.13
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 70.38 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.48 0.44 0.29 0.34 0.39 0.59 0.81 1.09 0.64 0.79 0.86
Long-Term Debt to Equity
0.35 0.44 0.29 0.34 0.00 0.00 0.00 0.85 0.45 0.52 0.51
Financial Leverage
-0.25 -0.22 -0.33 -0.05 0.14 0.22 -0.13 0.14 0.20 0.24 0.50
Leverage Ratio
1.79 1.80 1.89 2.01 2.17 2.44 2.40 2.63 2.37 2.79 3.19
Compound Leverage Factor
1.79 1.78 1.89 2.01 2.17 2.40 2.42 2.63 2.37 2.78 3.18
Debt to Total Capital
32.60% 30.59% 22.72% 25.19% 28.19% 37.27% 44.61% 52.17% 39.17% 44.27% 46.21%
Short-Term Debt to Total Capital
9.30% 0.00% 0.00% 0.00% 28.19% 37.27% 44.61% 11.73% 11.75% 15.56% 19.03%
Long-Term Debt to Total Capital
23.31% 30.59% 22.72% 25.19% 0.00% 0.00% 0.00% 40.45% 27.42% 28.72% 27.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
67.40% 69.41% 77.28% 74.81% 71.81% 62.73% 55.39% 47.83% 60.83% 55.73% 53.79%
Debt to EBITDA
-0.43 -0.33 -0.40 -0.52 -0.55 -0.47 -0.48 -0.50 -0.72 -0.97 -1.22
Net Debt to EBITDA
-0.07 -0.14 0.55 0.02 -0.29 -0.21 -0.36 -0.28 -0.21 -0.23 -0.51
Long-Term Debt to EBITDA
-0.31 -0.33 -0.40 -0.52 0.00 0.00 0.00 -0.39 -0.51 -0.63 -0.72
Debt to NOPAT
-0.50 -0.44 -0.52 -0.62 -0.66 -0.62 -0.64 -0.70 -0.75 -0.80 -0.85
Net Debt to NOPAT
-0.08 -0.18 0.71 0.02 -0.36 -0.28 -0.48 -0.39 -0.22 -0.19 -0.36
Long-Term Debt to NOPAT
-0.36 -0.44 -0.52 -0.62 0.00 0.00 0.00 -0.55 -0.53 -0.52 -0.50
Altman Z-Score
-0.50 -1.05 -0.07 -0.43 -1.12 -2.30 -2.62 -2.73 -2.43 -4.23 -4.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.37 3.66 5.06 4.99 1.94 1.76 1.61 2.22 2.41 2.11 1.89
Quick Ratio
1.25 1.37 2.98 2.46 0.89 0.81 0.59 0.89 1.13 0.85 0.72
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
5.91 7.72 18 -2.45 -6.35 0.69 -6.06 24 18 8.02 9.82
Operating Cash Flow to CapEx
0.00% -285.52% -48,630.00% -20,624.60% -7,781.76% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.21 0.31 0.36 0.49 0.54 0.58 0.44 0.51 0.54 0.58 0.72
Accounts Receivable Turnover
4.47 3.81 3.88 3.55 2.63 2.66 2.29 2.15 2.02 2.80 3.47
Inventory Turnover
0.82 0.96 1.08 1.15 1.18 1.40 1.24 1.37 1.50 1.41 1.48
Fixed Asset Turnover
2.07 2.68 3.38 4.35 4.49 5.39 5.16 5.76 6.20 8.82 11.38
Accounts Payable Turnover
11.81 16.21 17.44 20.53 9.49 8.90 10.54 12.35 7.34 7.59 10.76
Days Sales Outstanding (DSO)
81.65 95.83 93.99 102.79 138.84 137.01 159.45 169.39 181.00 130.57 105.25
Days Inventory Outstanding (DIO)
446.73 379.97 337.60 317.78 309.40 261.17 294.22 266.49 243.88 259.52 247.41
Days Payable Outstanding (DPO)
30.89 22.52 20.93 17.78 38.47 41.02 34.64 29.57 49.71 48.10 33.92
Cash Conversion Cycle (CCC)
497.49 453.29 410.66 402.79 409.77 357.16 419.03 406.31 375.17 341.99 318.74
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
62 53 40 58 62 43 40 30 37 28 27
Invested Capital Turnover
0.50 0.72 1.00 1.04 1.02 1.17 1.21 1.17 1.06 1.31 1.53
Increase / (Decrease) in Invested Capital
-15 -16 -25 -5.51 -0.43 -11 -0.42 -29 -25 -15 -13
Enterprise Value (EV)
65 56 52 54 47 35 40 36 29 25 27
Market Capitalization
61 47 79 54 36 26 24 25 23 21 20
Book Value per Share
$0.33 $0.25 $8.75 $7.52 $6.35 $4.19 $3.09 $2.21 $3.57 $2.05 $1.65
Tangible Book Value per Share
$0.33 $0.25 $8.75 $7.52 $6.35 $4.19 $3.09 $2.21 $3.57 $2.05 $1.65
Total Capital
85 65 88 79 71 54 45 38 51 42 37
Total Debt
28 20 20 20 20 20 20 20 20 19 17
Total Long-Term Debt
20 20 20 20 0.00 0.00 0.00 16 14 12 10
Net Debt
4.48 8.28 -27 -0.74 11 8.97 15 11 5.93 4.46 7.15
Capital Expenditures (CapEx)
-0.99 0.22 0.03 0.13 0.15 0.00 0.00 0.00 0.00 -0.02 -0.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)
49 40 43 59 58 45 43 32 29 19 18
Debt-free Net Working Capital (DFNWC)
72 52 90 80 67 56 48 41 43 33 28
Net Working Capital (NWC)
64 52 90 80 47 36 28 37 37 26 21
Net Nonoperating Expense (NNE)
5.27 5.55 3.83 1.71 3.73 8.78 3.70 2.55 -9.12 2.93 1.68
Net Nonoperating Obligations (NNO)
4.48 8.28 -27 -0.74 11 8.97 15 11 5.93 4.46 7.15
Total Depreciation and Amortization (D&A)
3.92 2.63 2.05 2.00 1.89 2.08 1.59 1.64 1.54 1.53 1.51
Debt-free, Cash-free Net Working Capital to Revenue
140.80% 90.92% 81.55% 93.13% 92.52% 79.71% 88.21% 62.63% 54.55% 40.61% 36.00%
Debt-free Net Working Capital to Revenue
208.09% 117.07% 170.79% 125.56% 107.13% 99.36% 97.98% 79.67% 81.47% 71.14% 55.18%
Net Working Capital to Revenue
185.22% 117.07% 170.79% 125.56% 75.39% 63.67% 56.94% 70.95% 69.99% 57.01% 41.55%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.40) ($2.32) ($1.80) ($1.23) ($1.32) ($2.53) ($1.26) ($0.91) $0.22 ($1.04) ($0.43)
Adjusted Weighted Average Basic Shares Outstanding
5.88M 5.79M 6.11M 7.86M 7.98M 7.50M 8.08M 8.29M 9.69M 9.36M 11.57M
Adjusted Diluted Earnings per Share
($2.40) ($2.32) ($1.80) ($1.23) ($1.32) ($2.53) ($1.26) ($0.91) $0.22 ($1.04) ($0.43)
Adjusted Weighted Average Diluted Shares Outstanding
5.88M 5.79M 6.11M 7.86M 7.98M 7.50M 8.08M 8.29M 9.75M 9.36M 11.57M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($2.32) $0.00 $0.00 $0.00 ($2.53) $0.00 $0.00 $0.00 ($1.04) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
5.93M 7.75M 7.87M 8.00M 8.03M 8.10M 8.31M 8.69M 11.33M 11.98M 12.12M
Normalized Net Operating Profit after Tax (NOPAT)
-8.84 -8.28 -7.17 -7.96 -6.78 -10 -6.49 -4.96 -4.90 -6.82 -3.27
Normalized NOPAT Margin
-52.93% -45.06% -54.48% -51.22% -42.96% -88.90% -110.36% -26.95% -29.67% -130.60% -29.17%
Pre Tax Income Margin
-84.48% -75.17% -83.56% -62.18% -66.55% -165.22% -173.06% -40.73% 12.85% -186.82% -44.08%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Xos, Inc. (NASDAQ: XOS) showed a mixed but slightly improving trend in Q1 2026, with revenue growing and operating cash burn narrowing versus recent loss-making quarters. However, the company remains unprofitable, still burns cash, and carries a meaningful debt load relative to its size.

  • Revenue rebounded sharply in Q1 2026. Operating revenue rose to $11.2 million from $5.2 million in Q4 2025 and $5.9 million in Q1 2025, showing a meaningful sequential and year-over-year improvement.
  • Gross profit turned positive and improved on a dollar basis. Gross profit was $4.3 million in Q1 2026, up from a gross loss of $2.6 million in Q4 2025.
  • Operating cash outflow improved materially. Cash used in operations was $1.6 million in Q1 2026 versus $4.8 million in Q1 2025 and $2.4 million in Q4 2025, suggesting better near-term cash discipline.
  • Cash increased slightly despite losses. Cash and equivalents ended Q1 2026 at $9.8 million, up from $8.8 million in Q2 2025 and above the Q1 2025 level of $4.8 million.
  • Inventory and working-capital levels are lower than a year ago. Inventory fell to $23.7 million from $38.0 million in Q1 2025, which may indicate a leaner balance sheet or improved inventory management.
  • Q1 2026 still featured sizable non-cash expenses. Depreciation and amortization totaled $1.5 million, which helped offset losses in the cash flow statement but does not change the underlying profitability challenge.
  • Recent quarterly results have been volatile. XOS posted a profit in Q3 2025, then a sharp loss in Q4 2025, and another loss in Q1 2026, making it difficult to call a stable turnaround yet.
  • Balance-sheet leverage remains important to watch. Total debt stood at $17.0 million at the end of Q1 2026, including $7.0 million of short-term debt and $10.0 million of long-term debt.
  • Share count has been moving around. Weighted average diluted shares were 11.6 million in Q1 2026 versus 8.3 million in Q2 2025 and 9.4 million in Q4 2025, which can complicate per-share comparisons.
  • XOS remains deeply unprofitable. The company reported a Q1 2026 net loss of $5.0 million, following a $9.8 million loss in Q4 2025 and a $10.2 million loss in Q1 2025.
  • Operating income was still negative. Q1 2026 operating loss was $4.7 million, showing the core business still does not cover operating expenses.
  • Financing cash flow was heavily negative. XOS used $2.9 million in financing activities in Q1 2026, driven by debt repayment and other financing outflows.
  • The business still depends on external financing and asset sales. Across the last several quarters, cash generation has been inconsistent, with the company often relying on debt issuance, equity issuance, or working-capital changes to support liquidity.
  • Historical comparisons show a challenging long-term trend. Revenue has not steadily translated into durable profitability, and the company has posted repeated quarterly losses over the last four years.

Bottom line: XOS showed some encouraging improvement in Q1 2026, especially in revenue, gross profit, and operating cash burn. But the company is still far from consistent profitability, and its balance sheet and debt obligations remain key risks for retail investors to monitor.

07/22/26 08:08 PM ETAI Generated. May Contain Errors.

XOS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, XOS's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

XOS's net income appears to be on an upward trend, with a most recent value of -$25.32 million in 2025, rising from -$16.67 million in 2020. The previous period was -$50.16 million in 2024. See XOS's forecast for analyst expectations on what's next for the company.

XOS's total operating income in 2025 was -$33.08 million, based on the following breakdown:
  • Total Gross Profit: $2.72 million
  • Total Operating Expenses: $35.81 million

Over the last 5 years, XOS's total revenue changed from $2.64 million in 2020 to $45.99 million in 2025, a change of 1,641.5%.

XOS's total liabilities were at $37.08 million at the end of 2025, a 42.7% decrease from 2024, and a 12.0% increase since 2020.

In the past 5 years, XOS's cash and equivalents has ranged from $10.36 million in 2020 to $35.63 million in 2022, and is currently $14.04 million as of their latest financial filing in 2025.

Over the last 5 years, XOS's book value per share changed from -0.58 in 2020 to 2.05 in 2025, a change of -454.1%.



Financial statements for NASDAQ:XOS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners